Standout Papers

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With... 2008 2026 2014 2020 913
  1. Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes (2008)
    Michael A. Nauck, Anders Frid et al. Diabetes Care
  2. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections (2017)
    Marcus Lind, William H. Polonsky et al. JAMA

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 82 standout
Sub-graph 1 of 18

Citing Papers

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
2024 Standout
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
2024 Standout

Works of Anders Frid being referenced

Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
2009

Author Peers

Author Last Decade Papers Cites
Anders Frid 3174 1046 1286 66 4.8k
Ranganath Muniyappa 1852 1459 883 84 6.2k
V. Wynn 3218 729 969 159 6.4k
Mark S. Cooper 3454 1419 997 135 7.0k
John N. Clore 3179 1091 1230 85 7.0k
Christophe De Block 3216 705 2321 180 6.7k
George Dimitriadis 2042 1410 1065 183 5.4k
Heikki Miettinen 2306 1005 1083 90 6.7k
W. Harry Hannon 3259 1314 763 107 7.5k
Martin Silink 3357 697 1374 131 7.1k
David J. Pettitt 3247 677 1374 64 5.9k

All Works

Loading papers...

Rankless by CCL
2026